Primary |
|
Blood Pressure Increased |
33.3% |
Drug Interaction |
33.3% |
Polyp |
33.3% |
|
Secondary |
Hypertension |
34.7% |
Coronary Artery Disease |
8.4% |
Atrial Fibrillation |
7.4% |
Multiple Drug Overdose |
7.4% |
Product Used For Unknown Indication |
6.3% |
Cardiac Failure |
4.2% |
Pain |
4.2% |
Diabetes Mellitus |
3.2% |
Infection Prophylaxis |
3.2% |
Arrhythmia |
2.1% |
Breast Cancer |
2.1% |
Constipation |
2.1% |
Essential Hypertension |
2.1% |
Infection |
2.1% |
Myocardial Infarction |
2.1% |
Osteoarthritis |
2.1% |
Renal Failure |
2.1% |
Thrombosis Prophylaxis |
2.1% |
Anticoagulant Therapy |
1.1% |
Candidiasis |
1.1% |
|
Hypertensive Crisis |
14.3% |
Intentional Self-injury |
9.5% |
Sinoatrial Block |
9.5% |
Stevens-johnson Syndrome |
9.5% |
Syncope |
9.5% |
Accommodation Disorder |
4.8% |
Blood Pressure Increased |
4.8% |
Bradycardia |
4.8% |
Drug Interaction |
4.8% |
Nausea |
4.8% |
Skin Fissures |
4.8% |
Tachycardia |
4.8% |
Toxic Epidermal Necrolysis |
4.8% |
Vomiting |
4.8% |
Weight Increased |
4.8% |
|
Concomitant |
Hypertension |
30.7% |
Product Used For Unknown Indication |
19.0% |
Drug Use For Unknown Indication |
10.0% |
Rheumatoid Arthritis |
7.8% |
Depression |
3.3% |
Type 2 Diabetes Mellitus |
3.2% |
Atrial Fibrillation |
2.9% |
Prophylaxis |
2.6% |
Diabetes Mellitus |
2.5% |
Coronary Artery Disease |
2.2% |
Pain |
2.2% |
Osteoporosis |
1.9% |
Myocardial Infarction |
1.7% |
Breast Cancer |
1.6% |
Diffuse Large B-cell Lymphoma |
1.6% |
Hyperlipidaemia |
1.6% |
Hypothyroidism |
1.4% |
Prostate Cancer |
1.4% |
Diabetic Neuropathy |
1.2% |
Renal Transplant |
1.2% |
|
Vomiting |
7.4% |
Myocardial Infarction |
6.5% |
Syncope |
6.5% |
Vertigo |
6.5% |
Cardiac Failure |
5.6% |
Hypertensive Crisis |
5.6% |
Nausea |
5.6% |
Weight Increased |
5.6% |
Cerebrovascular Accident |
4.6% |
Death |
4.6% |
Malaise |
4.6% |
Pancreatitis Acute |
4.6% |
Sepsis |
4.6% |
Tibia Fracture |
4.6% |
Urinary Tract Infection |
4.6% |
Convulsion |
3.7% |
Dermatitis Allergic |
3.7% |
Dyspnoea |
3.7% |
Long Qt Syndrome |
3.7% |
Pneumonia |
3.7% |
|
Interacting |
Drug Use For Unknown Indication |
25.0% |
Sedation |
25.0% |
Coronary Artery Disease |
16.7% |
Gastrointestinal Disorder |
16.7% |
Lipids |
16.7% |
|
Somnolence |
66.7% |
Drug Interaction |
16.7% |
Sudden Death |
16.7% |
|